Parallel and Overlapping Prevalence of Hepatitis B and C Viruses in Apparently Healthy Individuals in a Northern Nigerian Population Pennap, GRI and Chuga,

Slides:



Advertisements
Similar presentations
Saotharlann Náisiúnta Tagartha Viris UCD UCD National Virus Reference Laboratory Dr. Jeff Connell Assistant Director National Virus Reference Laboratory.
Advertisements

Treatment appropriate Normal or minimal hepatitis Chronic hepatitis Normal or inactive hepatitis Progressive fibrosis Cirrhosis HCC HBeAg Anti-HBe HBV.
FACTORS HINDERING ATTITUDE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN THE NIGER DELTA, NIGERIA by AGOFURE OTOVWE and OYEWOLE OYEDIRAN.
Hepatitis B 101 Clinical presentation of Hepatitis B Virus (HBV) indistinguishable from other hepatitis causes and is quite variable from asymptomatic.
Liver Disease and Thalassaemia George Constantinou.
Hepatitis B: Epidemiology
The changing pattern of viral hepatitis in Saudi Arabia Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital.
F. Kourgia, M. Vini, E. Zervou
Epidemiology and Control Programs for HBV Infection. Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
 Hepatitis B: Decreasing the Burden and Increasing Compliance Abby Wurzel, BSN, RNC Augustina Manuzak, MD, PhD, MPH.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Kerriann Parchment GI CBL 2 Part 3 December 2012 Viral hepatitis serology.
Module 3: HCV prevalence and course of HCV infection.
Washington D.C., USA, July 2012www.aids2012.org HCV genotype and HBV co-infection associate with HCV clearance in HIV- positive subjects Yuan Dong,
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Seroprevalence of HBV and HCV among Children in the Kilimanjaro Region, Tanzania Florida J. Muro, Suzanne P. Fiorillo, Christopher Odhiambo, Coleen K.
Hepatitis C- Global and National Perspective Dr Allister Grant Consultant Hepatologist University Hospitals Leicester NHS Trust.
Harold S. Margolis, M.D. Division of Viral Hepatitis
Hepatitis B Virus 28.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis D (Delta) Virus Division of Viral Hepatitis.
. In the name of God In the name of God. Epidemio logy.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
State of Hepatitis C- The Nigeria Experience Ghana 12 th August, 2013 Dr. Adegboyega Akere Lecturer/Consultant Physician & Gastroenterologist University.
World Hepatitis Day 2013, 29 th July Establishing a framework for better data collection and surveillance of Hepatitis in South Africa N. Prabdial-Sing.
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
Viral Hepatitis Australian Family Physician Vol. 30 No.5, May 2001 Presented by 郭詠怡 Date presented:25/8/2003.
Hepatitis B Virus Dr R V S N Sarma., M.D., [SLIDE 1] Title Slide
21th VHPB meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 RESIDUAL RISK OF TRANSFUSION-
HBV genotyping 12/21/07 Carrie Marshall. Received a send-out request for HBV genotyping on a 52y man.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
Prevalence of Hepatitis B infection in married women of child bearing age in District Islamabad Dr. Najma Javeed Awan Senior Medical Officer Pakistan Medical.
Sara Stevenson Hepatitis B Nurse Specialist St James’s Hospital, Leeds.
Introduction of Department of Molecular Biology for Public Health in SCDC Ye Lu Shanghai Municipal Center for Disease Control & Prevention Shanghai Institute.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
21/2/ Viral Hepatitis B (HBV) Associate Professor Family and Community Medicine Department King Saud University.
SEIEVA Integrated Epidemiological System for Acute Viral Hepatitis Alfonso Mele Catania, November
Prevalence and risk factors for self-reported sexually transmitted infections among adults in the Diepsloot informal settlement, Johannesburg, South Africa.
Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.
Hepatitis C Dr R V S N Sarma., M.D Consultant Physician.
Prevalence of hepatitis B and C viruses among human immunodeficiency virus infected children in Northern Nigeria. Pennap GRI, Yahuza, AJ and Abdulkarim,
Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.
HEPATITIS B VIRUS. Discovery and Development. Baruch S. Blumberg Fox Chase Cancer Center, Philadelphia PA, USA.
Serologic markers and molecular epidemiology of HBV from an HIV infected cohort from Cameroon Tshifhiwa Magoro 1, Emmaculate Nongpang 2, Lufuno Mavhandu.
Prevention of Viral Hepatitis B in Republic of Korea Ok Park, M.D., Ph.D., MPH Vaccine-Preventable Disease Control & National Immunization Program Korea.
Herpes Simplex Virus Type 2 infection among U.S. military service members: Public Health Implications and Opportunities for HIV Prevention Christian T.
Viral hepatitis overview Itodo Ewaoche 27/02/2015.
 Cytomegalovirus (CMV) is the commonest among viral infections during perinatal period that cause congenital infections  Seroprevalence in pregnant.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Viral Hepatitis.
Treatment of HBV/HCV Coinfection
Hepatitis C.
Hepatitis C: Overview and Epidemiology
Seroprevalence of Hepatitis B and C Markers among Inmates Entering the Nevada State Correctional System National Hepatitis Coordinators’ Conference, San.
Aminu M and Okpe Sunday Ejeh
Government of Swaziland
Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.
PREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG FEDERAL
Knowledge of transmission Sharing of sharp objects
Hepatology Hepatitis C virus (HCV) genotype 1b as a risk factor
Introduction Results Conclusions Methods
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
Higher Prevalence of HbsAg among Blood Donors at a tertiary care center in greater Gwalior: A 5years study ( TTI-12 : D-1182 ) Dr. Anita Arya, Dr. Sachin.
Hepatology Hepatitis C virus (HCV) genotype 1b as a risk factor
Division of Viral Hepatitis
HEPATITIS C BY MBBSPPT.COM
SERO-CHARACTERIZATION OF HUMAN CYTOMEGALOVIRUS AMONG PREGNANT WOMEN IN THIKA. PUBLISHERS: Zakayo Maingi (corresponding author) Dr Anthony Kebira Prof.
By: Antehun Alemayehu (M.Sc)
Presentation transcript:

Parallel and Overlapping Prevalence of Hepatitis B and C Viruses in Apparently Healthy Individuals in a Northern Nigerian Population Pennap, GRI and Chuga, F J Microbiology Unit Nasarawa State University, Keffi, Nigeria

Introduction  HBV and HCV are hepatotrophic viruses that cause acute and chronic hepatitis as well as latent hepatic infection.  Account for a substantial portion of Liver diseases worldwide – emerging global public health problems.  Both are endemic in Sub-Saharan Africa– highest prevalence of HCV is in Africa  Nigeria—35M people live with HBV and/or HCV  Infected persons can remain asymptomatic for decades but after years chronic carriers develop liver related ailments e.g. Liver failure, Liver cirrhosis and HCC.  Lethal duo – Coinfection results in more severe disease than either infection. Risk factors associated with HIV and HHV-8 infection

Introduction contd Transmission: Overlap-- parenterally( transfusion), sexually and vertically. In Africa – cultural practices(sexual rituals, scarification, piercing, contact sports, circumcision). Chronic HBV and HCV infections are defined by the detection of HBsAg and anti- HCV antibodies respectively. Good progress on antiviral therapy BUT as infections are largely ASYMPTOMATIC, patients who might benefit from treatment remain undetected. It is therefore very important to detect such carriers so as to: Reduce burden of illness and healthcare cost Reduce transmission through reduction of infected pool— reduction in viral load Vaccinate susceptible contacts of identified HBV carriers

Aims Numerous transfusion requiring ailments abound ---- depletion in donors Gains of ART -- hampered by coinfection with the duo It is important to sustain the gains of HAART and also have readily available blood donors. This study was therefore mooted to:  Determine the prevalence of HBV and HCV infections among apparently healthy people.  Determine the risk factors associated with infection. It is hoped that the findings will contribute to information required to make clinical decisions and set proactive health policies.

Materials and Methods Cross-sectional study Study population Ethical clearance Health talk and informed consent Sociodemographic information – questionnaire Sample collection Venipuncture – Serum ◦ storage (-4 0 C)  thawing (room temperature)  Screening procedure--- HBsAg and anti-HCV Rapid Test strips ( according to the Manufacturer’s instructions).

Results and Discussion  Population – 200 participants (48% males, 52% females)  General prevalence of hepatitis– 15%  Prevalence of HBV – 11.5%  Prevalence of HCV – 3.0%  Prevalence of coinfection – 0.5%  HBV in Nigeria – 16.5%(Pregnant women) 13.2%(General population) 7.9%(HIV population)  HCV in Nigeria -2.3%(HIV population) 4.5%(General population) 0.8%(Pregnant population)

Result and Discussion contd. Probable reasons for differences in prevalence Type of population studied Geographic region Socoieconomic status Cultural practices Method of viral detection HBsAg negative (in cases of occult infection i.e –ve HBsAg but detectable HBV DNA)

Figure 1: Prevalence of Hepatitis B and C virus infections among apparently healthy individuals in relation to age

Figure 2: Prevalence of Hepatitis B and C virus infections among apparently healthy individuals in relation to gender

Figure 3: Prevalence of Hepatitis B and C virus infections among apparently healthy individuals in relation to marital status

Figure 4: Prevalence of Hepatitis B and C virus infections among apparently healthy individuals in relation to history of blood transfusion

Figure 6: Prevalence of Hepatitis B and C virus infections among apparently healthy individuals in relation to Educational background

Figure 7: Prevalence of Hepatitis B and C virus infections among apparently healthy individuals in relation to occupation

Figure 8: Prevalence of Hepatitis B and C virus infections among apparently healthy individuals in relation to Facial marks

Conclusion This study reported infection with HBV (11.5%), HCV(3.0%) and HBV-HCV coinfection(0.5%) in apparently healthy participants. Study confirms the endemicity of these viruses in the study area. High prevalence in apparently healthy people is a cause for alarm. No identifiable risk factors Not identifying risk factors has drawn attention to the probability of obscured risk factors or locality specific risk factors.

Recommendation These findings underscore the importance of screening apparently healthy people for these viruses. Screening should be available and affordable Evaluate salient social and cultural practices that may facilitate transmission Institute proactive strategies for prevention and control

Future Work Larger studies Longitudinal studies Inclusion of more probable risk factors( viz-a-viz sociocultural practices of the study area) Molecular study of circulating strains

Acknowledgement We wish to sincerely thank:  All the study participants  Staff of Innovative Biotechnology Laboratory for technical support  Dr DS Nyabam for statistical analysis..

References Udeze et al. (2011). Hepatitis C virus antibody detection among first year students of University of Ilorin, Nigeria. World Journal of Medical Science 6(3) Kolawale et al.(2012).Hepatitis B antigenemia and its effects on hematological parameters in pregnant women in Osogbo. Journal of Virology 9:317 Tremeau-Bravard et al.(2012). Seroprevalence of Hepatitis B and C infection among HIV positive population in Auja, Nigeria. African Health Science. 12(3) Dawurung et al. (2012). Archives of Applied Science Research. 4(4)

Screening asymptomatic persons is an IMPORTANT instrument in disease detection especially in silent killers like HBV and HCV infections. T H A N K YOU